Search research articles
Contact Us
Filters
Showing results (61-70 of 228) with videos related to
Page
of 23
Sort By:
Gut
|
December 1, 1977
Changes in the plasma clearance and protein binding of carbenoxolone with age, and their possible relationship with adverse drug effects
M J Hayes, M Sprackling, M J Langman
Therapeutic Drug Monitoring
|
July 17, 2014
High-throughput method for the quantification of lacosamide in serum using ultrafast SPE-MS/MS
Eric Korman, Loralie J Langman, Paul J Jannetto
British Medical Journal
|
January 3, 1976
Hospital admissions for peptic ulcer during 1958-72
R C Brown, M J Langman, P M Lambert
Clinical Biochemistry
|
December 7, 2019
The challenge that chlorine presented during the development of a benzodiazepine assay
Richard G Lahr, Paul J Jannetto, Loralie J Langman
Journal of Analytical Toxicology
|
August 12, 2003
Fatal acute topiramate toxicity
Loralie J Langman, Henry A Kaliciak, Sharon A Boone
Cancer Research
|
February 1, 1996
Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid
K F Kane, M J Langman, G R Williams
Journal of the American Academy of Dermatology
|
August 14, 2012
Therapeutic dose monitoring of mycophenolate mofetil in dermatologic diseases
Olayemi Sokumbi, Rokea A el-Azhary, Loralie J Langman
British Medical Journal
|
July 14, 1973
Treatment of chronic gastric ulcer with carbenoxolone and gefarnate: a comparative trial
M J Langman, D R Knapp, E J Wakley
Clinical Chemistry
|
June 1, 1993
Cross-reactivities of cyclosporin G (NVa2 cyclosporin) and metabolites in cyclosporin A immunoassays
R W Yatscoff, L J Langman, D F LeGatt
British Journal of Clinical Pharmacology
|
February 1, 1975
Changes in drug metabolism with increasing age: 1. warfarin binding and plasma proteins
M J Hayes, M J Langman, A H Short
Page
of 23
Search research articles
Search
Showing results (61-70 of 228) with videos related to
Sort By:
Page
of 23
Gut
|
December 1, 1977
Changes in the plasma clearance and protein binding of carbenoxolone with age, and their possible relationship with adverse drug effects
M J Hayes, M Sprackling, M J Langman
Therapeutic Drug Monitoring
|
July 17, 2014
High-throughput method for the quantification of lacosamide in serum using ultrafast SPE-MS/MS
Eric Korman, Loralie J Langman, Paul J Jannetto
British Medical Journal
|
January 3, 1976
Hospital admissions for peptic ulcer during 1958-72
R C Brown, M J Langman, P M Lambert
Clinical Biochemistry
|
December 7, 2019
The challenge that chlorine presented during the development of a benzodiazepine assay
Richard G Lahr, Paul J Jannetto, Loralie J Langman
Journal of Analytical Toxicology
|
August 12, 2003
Fatal acute topiramate toxicity
Loralie J Langman, Henry A Kaliciak, Sharon A Boone
Cancer Research
|
February 1, 1996
Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid
K F Kane, M J Langman, G R Williams
Journal of the American Academy of Dermatology
|
August 14, 2012
Therapeutic dose monitoring of mycophenolate mofetil in dermatologic diseases
Olayemi Sokumbi, Rokea A el-Azhary, Loralie J Langman
British Medical Journal
|
July 14, 1973
Treatment of chronic gastric ulcer with carbenoxolone and gefarnate: a comparative trial
M J Langman, D R Knapp, E J Wakley
Clinical Chemistry
|
June 1, 1993
Cross-reactivities of cyclosporin G (NVa2 cyclosporin) and metabolites in cyclosporin A immunoassays
R W Yatscoff, L J Langman, D F LeGatt
British Journal of Clinical Pharmacology
|
February 1, 1975
Changes in drug metabolism with increasing age: 1. warfarin binding and plasma proteins
M J Hayes, M J Langman, A H Short
Page
of 23